{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T14:15:55Z","timestamp":1770905755648,"version":"3.50.1"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T00:00:00Z","timestamp":1768262400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T00:00:00Z","timestamp":1768262400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ophthalmol Ther"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s40123-026-01308-1","type":"journal-article","created":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T20:48:25Z","timestamp":1768337305000},"page":"503-510","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Tele-Ophthalmology for Retinal Health Surveillance in Denmark"],"prefix":"10.1007","volume":"15","author":[{"given":"Marie L. R.","family":"Rasmussen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danson V.","family":"Muttuvelu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lasse J.","family":"Cehofski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jakob","family":"Grauslund","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josef","family":"Huemer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pearse A.","family":"Keane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tor P.","family":"Utheim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tunde","family":"Peto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Goran","family":"Petrovski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles C.","family":"Wykoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6620-5365","authenticated-orcid":false,"given":"Yousif","family":"Subhi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,13]]},"reference":[{"key":"1308_CR1","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1093\/oxfordjournals.epirev.a036021","volume":"10","author":"SB Thacker","year":"1988","unstructured":"Thacker SB, Berkelman RL. Public health surveillance in the United States. Epidemiol Rev. 1988;10:164\u201390.","journal-title":"Epidemiol Rev"},{"key":"1308_CR2","first-page":"1","volume":"50","author":"RR German","year":"2001","unstructured":"German RR, Lee LM, Horan JM, et al. Updated guidelines for evaluating public health surveillance systems: recommendations from the Guidelines Working Group. MMWR Recomm Rep. 2001;50:1-CE7.","journal-title":"MMWR Recomm Rep"},{"key":"1308_CR3","unstructured":"World Health Organization. Noncommunicable disease surveillance, monitoring and reporting. NCD global monitoring framework. https:\/\/www.who.int\/teams\/ncds\/surveillance\/monitoring-capacity\/gmf. Accessed 19 Oct 2025."},{"key":"1308_CR4","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1093\/oxfordjournals.aje.a117261","volume":"140","author":"SB Thacker","year":"1994","unstructured":"Thacker SB, Stroup DF. Future directions for comprehensive public health surveillance and health information systems in the United States. Am J Epidemiol. 1994;140:383\u201397.","journal-title":"Am J Epidemiol"},{"key":"1308_CR5","doi-asserted-by":"publisher","first-page":"449","DOI":"10.2147\/CLEP.S91125","volume":"7","author":"M Schmidt","year":"2015","unstructured":"Schmidt M, Schmidt SA, Sandegaard JL, Ehrenstein V, Pedersen L, S\u00f8rensen HT. The Danish National Patient Registry: a review of content, data quality, and research potential. Clin Epidemiol. 2015;7:449\u201390.","journal-title":"Clin Epidemiol"},{"key":"1308_CR6","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s10654-014-9930-3","volume":"29","author":"M Schmidt","year":"2014","unstructured":"Schmidt M, Pedersen L, S\u00f8rensen HT. The Danish Civil Registration System as a tool in epidemiology. Eur J Epidemiol. 2014;29:541\u20139.","journal-title":"Eur J Epidemiol"},{"key":"1308_CR7","volume":"70","author":"ST S\u00f8rensen","year":"2023","unstructured":"S\u00f8rensen ST, Kristensen FP, Troelsen FS, Schmidt M, S\u00f8rensen HT. Health registries as research tools: a review of methodological key issues. Dan Med J. 2023;70:A12220796.","journal-title":"Dan Med J"},{"key":"1308_CR8","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1111\/aos.16727","volume":"102","author":"BS Thinggaard","year":"2024","unstructured":"Thinggaard BS, Pedersen F, Kawasaki R, et al. Risk of post-injection endophthalmitis peaks within the first three injections of anti-vascular endothelial growth factor therapy: a nationwide registry-based study. Acta Ophthalmol. 2024;102:953\u201362.","journal-title":"Acta Ophthalmol"},{"key":"1308_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.xops.2023.100291","volume":"3","author":"S Dinesen","year":"2023","unstructured":"Dinesen S, Stokholm L, Subhi Y, et al. Five-year incidence of proliferative diabetic retinopathy and associated risk factors in a nationwide cohort of 201 945 Danish patients with diabetes. Ophthalmol Sci. 2023;3:100291.","journal-title":"Ophthalmol Sci"},{"key":"1308_CR10","doi-asserted-by":"publisher","DOI":"10.1111\/aos.17579","author":"BR Nielsen","year":"2025","unstructured":"Nielsen BR, la Cour M, Alberti M, et al. Risk of rhegmatogenous retinal detachment following pars plana vitrectomy for full-thickness macular hole and epiretinal membrane in pseudophakic eyes. Acta Ophthalmol. 2025. https:\/\/doi.org\/10.1111\/aos.17579.","journal-title":"Acta Ophthalmol"},{"key":"1308_CR11","doi-asserted-by":"publisher","first-page":"2977","DOI":"10.4103\/ijo.IJO_1442_21","volume":"69","author":"K Ramasamy","year":"2021","unstructured":"Ramasamy K, Mishra C, Kannan NB, Namperumalsamy P, Sen S. Telemedicine in diabetic retinopathy screening in India. Indian J Ophthalmol. 2021;69:2977\u201386.","journal-title":"Indian J Ophthalmol"},{"key":"1308_CR12","volume":"72","author":"IN Frederiksen","year":"2024","unstructured":"Frederiksen IN, Muttuvelu DV, Subhi Y, Rasmussen ML. Components of eye health checks provided by optician retail stores in Denmark. Dan Med J. 2024;72:A05240301.","journal-title":"Dan Med J"},{"key":"1308_CR13","unstructured":"Sundhedspolitisk Tidsskrift. [\u00d8jenl\u00e6ger: Vi spilder tid og ressourcer p\u00e5 raske patienter, som henvises af optikere]. https:\/\/sundhedspolitisktidsskrift.dk\/nyheder\/sundhedspolitik\/8171-ojenlaeger-vi-spilder-tid-og-ressourcer-pa-raske-patienter-som-henvises-af-optikere.html. In Danish. Accessed 19 Oct 2025."},{"key":"1308_CR14","doi-asserted-by":"publisher","DOI":"10.1136\/bmjophth-2020-000671","volume":"6","author":"DV Muttuvelu","year":"2021","unstructured":"Muttuvelu DV, Buchholt H, Nygaard M, Rasmussen MLR, Sim D. Danish teleophthalmology platform reduces optometry referrals into the national eye care system. BMJ Open Ophthalmol. 2021;6:e000671.","journal-title":"BMJ Open Ophthalmol"},{"key":"1308_CR15","doi-asserted-by":"publisher","first-page":"2788","DOI":"10.1038\/s41433-024-03156-4","volume":"38","author":"EP J\u00f8rgensen","year":"2024","unstructured":"J\u00f8rgensen EP, Muttuvelu DV, Peto T, et al. Implementing teleophthalmology services to improve cost-effectiveness of the national eye care system. Eye (Lond). 2024;38:2788\u201395.","journal-title":"Eye (Lond)"},{"key":"1308_CR16","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.1007\/s40123-024-01008-8","volume":"13","author":"MLR Rasmussen","year":"2024","unstructured":"Rasmussen MLR, Cehofski LJ, Davies J, et al. The impact of the COVID-19 pandemic on tele-ophthalmology-based retinal screening. Ophthalmol Ther. 2024;13:2467\u201380.","journal-title":"Ophthalmol Ther"},{"key":"1308_CR17","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1016\/j.amepre.2011.08.015","volume":"41","author":"LM Lee","year":"2011","unstructured":"Lee LM, Thacker SB. Public health surveillance and knowing about health in the context of growing sources of health data. Am J Prev Med. 2011;41:636\u201340.","journal-title":"Am J Prev Med"},{"key":"1308_CR18","doi-asserted-by":"publisher","DOI":"10.1080\/09296174.2013.830554","volume":"20","author":"S Wallis","year":"2013","unstructured":"Wallis S. Z-squared: the origin and application of \u03c72. J Quant Linguist. 2013;20:10.","journal-title":"J Quant Linguist"},{"key":"1308_CR19","unstructured":"Statistics Denmark. Population figures. 2025. https:\/\/www.dst.dk\/en\/Statistik\/emner\/borgere\/befolkning\/befolkningstal. Accessed 13 Dec 2025."}],"container-title":["Ophthalmology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40123-026-01308-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40123-026-01308-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40123-026-01308-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T13:26:16Z","timestamp":1770902776000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40123-026-01308-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,13]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["1308"],"URL":"https:\/\/doi.org\/10.1007\/s40123-026-01308-1","relation":{},"ISSN":["2193-8245","2193-6528"],"issn-type":[{"value":"2193-8245","type":"print"},{"value":"2193-6528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,13]]},"assertion":[{"value":"29 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Marie L.R. Rasmussen declares to have received speaker fee for lectures from Santen, and to have received advisory board honorarium from Santen. Danson V. Muttuvelu declares to have received consultancy honorarium from Alcon. Lasse J. Cehofski declares to have received speaker fees from AbbVie, Bayer, and Roche, and to have served as an advisory board member for AbbVie, Bayer, Novartis, and Roche. Jakob Grauslund declares to have received speaker fees from Allergan, Bayer, Novartis, and Roche, and to have served as an advisory board member for Allergan, Apellis, Bayer, Novartis, and Roche. Pearse A. Keane declares speaker fees from Heidelberg Engineering, Topcon, Allergan, and Bayer; consultancy honorarium from Google, DeepMind, Roche, Novartis, Apellis, and\u00a0BitFount; and equity ownership in Big Picture Medical. Tor P. Utheim is co-founder and co-owner of The Norwegian Dry Eye Clinic\/T\u00f8rre\u00f8yneklinikken and the Clinic of Eye Health\/\u00d8yehelseklinikken, Oslo, Norway, which delivers talks for and\/or receives financial support from the following: ABIGO, Alcon, Allergan, AMWO, Bausch&Lomb, Bayer, European School for Advanced Studies in Ophthalmology, InnZ Medical, Medilens Nordic, Medistim, Novartis, Santen, Specsavers, Shire Pharmaceuticals, and Thea Laboratories. Goran Petrovski declares to have received consultancy honorarium from AbbVie and Roche, and serves on the advisory board of Bulbitech, Profundus, RetinaRISK and Astellas. Charles C. Wykoff declares consultancy work for 4DMT, AbbVie, Adverum Biotechnologies, Aerie, AGTC, Alcon, Alimera, Allergan, Allgenesis, Alnylam, Annexon Biosciences, Apellis, Arrowhead, Ascidian, Bausch\u2009+\u2009Lomb, Bayer, Bionic Vision Technologies, Boehringer Ingelheim, Cholgene, Clearside Biomedical, Curacle, Eyebiotech, EyePoint Pharmaceuticals, Foresite, Frontera Therapeutics, Genentech, Gyroscope Therapeutics, IACTA, IVERIC bio, Janssen, Kato Pharma, Kiora, Kodiak Sciences, Kriya Therapeutics, Merck, Nanoscope, Neurotech, NGM Biopharmaceuticals, Notal Vision, Novartis, OccuRx, Ocular Therapeutix, Ocuphire, OcuTerra, OliX, ONL, Opthea, Oxular, Palatin Technologies, Perceive Bio, Perfuse, PolyPhotonix, Ray, RecensMedical, Regeneron, REGENXBIO, Resonance, Roche, Sandoz, Sanofi, SciNeuro Pharmaceuticals, Stealth Biotherapeutics, Surrozen, Suzhou Raymon, Takeda, Thea, Therini, TissueGen, Valo, and Verana Health; research funding from 4DMT, Adverum Biotechnologies, AffaMed Therapeutics, Aldeyra, Alexion, Alimera, Alkahest, Allergan, Allgenesis, Amgen, Annexin Pharmaceuticals, Annexon Biosciences, Apellis, AsclepiX Therapeutics, Bayer, Boehringer Ingelheim, Chengdu Kanghong, Clearside Biomedical, Curacle, Eyebiotech, EyePoint Pharmaceuticals, Gemini, Genentech, GlaxoSmithKline, Graybug Vision, Gyroscope Therapeutics, IONIS, iRENIX, IVERIC bio, Janssen, Kodiak Sciences, LMRI, McMaster University, Nanoscope, Neurotech, NGM Biopharmaceuticals, Novartis, Ocular Therapeutix, Ocuphire, OcuTerra, OliX, Ophthotech, Opthea, Oxurion, Oxular, Oyster Point Pharma, Perceive Bio, RecensMedical, Regeneron, REGENXBIO, Rezolute, Roche, Sam Chun Dang Pharm, Sandoz, Senju Pharmaceutical, Shanghai Henlius Biotech, Taiwan Liposome Company, Unity Biotechnology, Verily Life Sciences, and Xbrane Biopharma; on the advisory board of Aeri and Kato Pharma; board member of ASRS, Vit-Buckle Society; and stock options for ONL, PolyPhotonix, RecensMedical, TissueGen, Visgenx, and Vitranu. Yousif Subhi declares to have received speaker fees from Bayer and Roche, and to be the inventor of a patent related to the use of biomarkers of polypoidal choroidal vasculopathy (WO2020007612A1). Yousif Subhi is Section Editor of\n                      Ophthalmology and Therapy\n                      . Yousif Subhi was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions. Josef Huemer declares to have received speaker fees from Bayer, Roche and Zeiss, and travel support from Roche, Bayer and Alimera. Tunde Peto declares no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"All aspects of this study followed the tenets of the Declaration of Helsinki. All patients provided mandatory consent to data processing and company policies prior to data sharing. All data storage and data management aspects comply with the standards of European Union General Data Protection Regulation. All data extracted were fully anonymous and are classified as quality assessment, hence neither ethics approval is needed nor any permission for the use of the data according to The Danish Data Protection Agency. Data were extracted from Louis Nielsen A\/S and Mit\u00d8je Aps and were accessible to author Danson V. Muttuvelu.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}